Molecular mechanism of herbs in human lung cancer cells

Journal of the Medical Association of Thailand

Volumn 88, Issue 11, 2005, Pages 1725-1734

  Kummalue, Tanawan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antiproliferative effect; Drug development; Herbs; Plant derived compounds

Indexed keywords

ACACETIN; ANGELICA SINENSIS EXTRACT; BUPLEURUM EXTRACT; COXILACHRYMA EXTRACT; CURCUMA LONGA EXTRACT; FLAVANOID; HERBACEOUS AGENT; ISOLIQUIRITIGENIN; LITHOSPERMUM RADIX EXTRACT; PACLITAXEL; PLANT EXTRACT; PROTEIN P53; SAIKOSAPONIN D; SCUTELLARIA BARBATA EXTRACT; SOLANIUM INCANUM EXTRACT; STILBENOID DERIVATIVE; THALICTRUM ACUTIFOLIUM EXTRACT; TRIPTERYGIUM WILFORDII EXTRACT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANGELICA SINENSIS; APOPTOSIS; BUPLEURUM; CANCER; CANCER CELL; CONTROLLED STUDY; COXILACHRYMA; CURCUMA LONGA; CYTOTOXICITY; DRUG MECHANISM; HERB; HERBAL MEDICINE; HUMAN; HUMAN CELL; INFECTION; LITHOSPERMUM RADIX; LUNG CANCER; REVIEW; SCUTELLARIA; SOLANUM; TAXUS BREVIFOLIA; THALICTRUM ACUTIFOLIUM; TRIPTERYGIUM; TUMOR SUPPRESSOR GENE; DRUG EFFECT; LUNG TUMOR; MEDICINAL PLANT; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; HUMANS; LUNG NEOPLASMS; MEDICINE, HERBAL; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION;

EID: 33645213206     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Greenlee RT, Hill-Marmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 51: 7-33.
3. Martin N, Pongnikorn S. Cancer in Thailand, vol. III, 1995-1997. Bangkok: Bangkok Medical Publisher, 2003: 44-8.
4. Fong KM, Sekido Y, Gazdar AF, Minna JD. Lung cancer.9: molecular biology of lung cancer: clinical implications. Thorax 2003; 58: 892-900.
5. Massion PP, Carbone DP. The molecular basis of lung cancer: molecular abnormalities And therapeutic implications. Respir Res 2003; 4: 12.
6. Schwartsmann G, Ratain MJ, Cragg GM, Wong JE, Sijo N, Parkinson DR, et al. Anticancer drug discovery and development throughout the world. J Clin Oncol 2002; 20: 47s-59s.
7. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data and methodological considerations for phase I and II trials. Cancer Inv 2002; 20: 1069-79.
8. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven Therapy: a 5 year follow up study. J Clin Oncol 1998; 16: 6-12.
9. Bonham M, Arnold H, Montgomery M, Nelson PS. Molecular effects of the herbal compound PC-SPEC: identification of activity pathways in prostate carcinoma. Cancer Res 2002; 62: 3920-24.
10. Hu H, Ahn NS, Yang X, lee YS, Kang KS. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 2002; 102: 250-3.
11. Hadfield JA, Ducki S, Hirst N, McGown AT. Tubulin and microtubules as targets for anticancer drugs. Prog in Cell Cycle Res 2003; 5: 309-25.
12. Yang YL, Li XM. The IAP family:endogenous caspase inhibitors with multiple biological activities. Cell Res 2000; 10: 169-77.
13. Wei H, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2002; 4: 721-9.
14. Guinea MC, Parellada J, Lacaille-Dubois MA, Wagner H. Biologically active triterpene Saponins from Bupleurum fruticosum. Planta Med 1994; 60: 163-7.
15. Hsu YL, Kuo PL, Lin CC. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci 2004; 75: 1231-42.
16. Pillai GR, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 2004; 208: 163-70.
17. Tao X, Lipsky P. The Chinese inflammatory and immunosuppressive herbal remedy Triptery-gium wilfordii Hook F. Rheum Dis Clin North Am 2000; 26: 29-50.
18. Kusunoki N, Yamazaki R, Kitasato H, Beppu M, Aoki H, Kawai S. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol 2004; 4: 2.
19. Kupchan SM, Court WA, Dailey RG, Gilmore CJ, Bryan RT. Triptolide and tripdiolide, novel antileukemic, diterpenoid triepoxides from Tripterygium wilfordii Hook F. J Am Chem Soc 1972; 94: 7194-5.
20. Lee KY, Chang W, Qiu D, Kao PN, Rosen GD. PG490 (triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J Biol Chem 1999;274:13451-5.
21. Chang WT, Kang JJ, Lee KY, Wei K, Anderson E, Gotmare S, et al. Triptolide and chemotherapy cooperate in tumor with apoptosis. A role for p53 pathway. J Biol Chem 2001; 276: 2221-7.
22. Fidler J, Li K, Chung C, Wei K, Ross JA, Jessica AR, et al. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol Cancer Ther 2003; 2: 855-62.
23. Frese S, Pirnia F, Miescher D, Krajewski S, Borner MM, Reed JC, et al. PG490 mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activates of ERK2. Oncogene 2003; 22: 5427-35.
24. Cody V. Crystal and molecular structures of flavonoids. Prog Clin Biol Res 1988; 280: 29-44.
25. Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adult in The Natherlands. Nutr Cancer 1993; 20: 21-9.
26. Cholbi MR, Paya M, Alcaraz M.J. Inhibitory effects of phenolic compounds on CC14-induced microsomal lipid peroxidation. Experientia 1991; 47: 195-9.
27. Liao YH, Houghton PJ, Hoult JR. Novel and known constituents from buddleja species and their activities against leukocyte eicosanoid generation. J Nat Prod 1999; 62: 1241-5.
28. Kraft C, Jenett-Siems K, Siems K, Jakupovic J, Mavi S, Bienzle U, et al. In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phyther Res 2003; 17: 123-8.
29. Hsu LY, Kuo PL, Liu CF, Lin CC. Acacetin-induced cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Cancer Lett 2004; 212: 53-60.
30. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med 1997; 23: 302-13.
31. Chan SC, Chang YS, Wang JP, Chen SC, Kuo SC. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med 1998; 64: 153-8.
32. Hsu LY, Kuo PL, Chiang LC, Lin CC. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer A549 cells. Clin Exp Pharm Physio 2004; 31: 414-8.
33. Frankel EN, Waterhouse AC, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-4.
34. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-20.
35. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer lett 2000; 158: 85-91.
36. Lee EJ, Min HY, Park HJ, Chung HJ, Kim S, Han YN, et al. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4′- bromocis-stilbene, in human lung cancer cells. Life Sci 2004; 75: 2829-39.
37. Cheng YL, Chang WL, Lee SC, Liu YG, Chen CJ, Lin SZ, et al. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci 2004; 75: 1579-94.
38. Boklan J, Nanjangud G, MacKenzie KL, May C, Sadelain M, Moore MA, et al. Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts. Cancer Res 2002; 62: 2104-14.
39. Cheng YL, Chang WL, Lee SC, Liu YG, Lin YG, Chen CJ, et al. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci 2003; 73: 2383-94.
40. Chang HC, Huang YC, Hung WC. Antiproliferative and chemopreventive effects of Adlay seed on lung cancer in vitro and in vivo. J Agric Food Chem 2003; 51: 3656-60.
41. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by □-hydroxyisovalerylshikonin. J Biol Chem 2004; 29: 42503-15.
42. Chen Q, Peng W, Qi S, Xu A. Apoptosis of human highly metastatic lung cancer cell line 95-D induced by acutiaporberine, a novel bisalkaloid derived from Thalictrum acutifolium. Planta Med 2002; 68: 550-3.
43. Chen Q, Peng W, Xu A. Apoptosis of a human non-small lung cancer (NSCLC) cell line, PLA-801, induced by acutiaporberine, a novel bisalkaloid derived from Thalictrum acutifolium (Hand.-Mazz) Boivin Biochem Pharm 2002; 63: 1389-96.
44. Yin X, Zhou J, Jie C, Xing D, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004; 75: 2233-4.
45. Kuo KW, Hsu SH, Li YP, Lin WL, Liu LF, Chang LC, et al. Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. Biochem Pharm 2000; 60: 1865-73.
46. Maruo VM, Bernardi MM, Spinosa HS. Toxicological evaluations of long-term consumption of Solanum lycocarpum St. Hill fruits in male and female adult rats. Phytomedicine 2003; 10: 48-52.
47. Liang CH, Liu LF, Shiu LY, Huang YS, Chang LC, Kao KW, et al. Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells. Biochem Biophys Res Comm 2004; 322: 751-8.
48. May P, May E. Twenty years of p53 research structural and functional aspects of the p53 protein. Oncogene 1999; 18: 7621-36.
49. Brown JM, Wouters BG. Apoptosis p53 and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59: 1391-9.
50. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
51. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
52. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-78.
53. Ferreira CG, Tolis C, Span SW, Peters GJ, Van Lopik T, Kummer AJ, et al. Drug induced apoptosis in lung cancer cells is not mediated by the Fas/FasL. (CE95/APO1) signaling pathway. Clin Cancer Res. 2000; 6: 203-12.
54. Schiff PB, Fant J, Horwiz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979; 277: 655-7.